GB903866A - Therapeutic preparations containing 7-substituted theophylline derivatives - Google Patents
Therapeutic preparations containing 7-substituted theophylline derivativesInfo
- Publication number
- GB903866A GB903866A GB1687461A GB1687461A GB903866A GB 903866 A GB903866 A GB 903866A GB 1687461 A GB1687461 A GB 1687461A GB 1687461 A GB1687461 A GB 1687461A GB 903866 A GB903866 A GB 903866A
- Authority
- GB
- United Kingdom
- Prior art keywords
- theophylline
- beta
- substituted
- preparations containing
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical class O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 3
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 abstract 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
- WUVBGOGAIVZQNC-UHFFFAOYSA-N 4-(1-amino-1-hydroxy-2-methylpropyl)benzene-1,2-diol Chemical compound OC=1C=C(C=CC1O)C(C(C)C)(O)N WUVBGOGAIVZQNC-UHFFFAOYSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 1
- 229960000583 acetic acid Drugs 0.000 abstract 1
- 230000001800 adrenalinergic effect Effects 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 229940125717 barbiturate Drugs 0.000 abstract 1
- HNYOPLTXPVRDBG-UHFFFAOYSA-N barbituric acid Chemical compound O=C1CC(=O)NC(=O)N1 HNYOPLTXPVRDBG-UHFFFAOYSA-N 0.000 abstract 1
- STDBAQMTJLUMFW-UHFFFAOYSA-N butobarbital Chemical compound CCCCC1(CC)C(=O)NC(=O)NC1=O STDBAQMTJLUMFW-UHFFFAOYSA-N 0.000 abstract 1
- 229960003874 butobarbital Drugs 0.000 abstract 1
- 229960001948 caffeine Drugs 0.000 abstract 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- KSCFJBIXMNOVSH-UHFFFAOYSA-N dyphylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1N(CC(O)CO)C=N2 KSCFJBIXMNOVSH-UHFFFAOYSA-N 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000003170 musculotropic effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- VYGBQXDNOUHIBZ-UHFFFAOYSA-L sodium formaldehyde sulphoxylate Chemical compound [Na+].[Na+].O=C.[O-]S[O-] VYGBQXDNOUHIBZ-UHFFFAOYSA-L 0.000 abstract 1
- 239000004289 sodium hydrogen sulphite Substances 0.000 abstract 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 229960000278 theophylline Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A therapeutic preparation for the treatment of asthma comprises (a) a purine component having a musculotropic action which is a water-soluble 7-substituted thiophylline derivative and (b) an adrenergic component which is the hydrochloride of 1-(3,4-dihydroxyphenyl)-2-methyl-amino-1-propanol. Specified theophylline derivatives are 7-beta-hydroxyethyl theophylline, 7-beta-gamma dihydroxypropyl theophylline and a salt of theophylline-7-ethanoic acid. The preparation may be used orally, e.g. as a tablet, parenterally, e.g. in aqueous solution, as an aerosol or as a suppository. Optional ingredients are (a) barbiturate drugs such as butobarbital and butylethyl-malonylurea, (b) antioxidant or reducing agent, e.g. sodium bisulphite or sodium formaldehyde sulphoxylate, (c) theophylline, theophylline ethylenediamine and caffeine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1687461A GB903866A (en) | 1961-05-09 | 1961-05-09 | Therapeutic preparations containing 7-substituted theophylline derivatives |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1687461A GB903866A (en) | 1961-05-09 | 1961-05-09 | Therapeutic preparations containing 7-substituted theophylline derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB903866A true GB903866A (en) | 1962-08-22 |
Family
ID=10085233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1687461A Expired GB903866A (en) | 1961-05-09 | 1961-05-09 | Therapeutic preparations containing 7-substituted theophylline derivatives |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB903866A (en) |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000000184A3 (en) * | 1998-06-26 | 2000-11-09 | Elaine A Delack | Use of histamine h2 mimicking substances for the treatment of multiple sclerosis |
| WO2003057188A1 (en) * | 2001-11-21 | 2003-07-17 | Alexza Molecular Delivery Corporation | Delivery of caffeine through an inhalation route |
| US7090830B2 (en) | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| US7232830B2 (en) | 1998-06-26 | 2007-06-19 | Elaine A Delack | Method for treatment of neurodegenerative diseases and effects of aging |
| US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
| US7537009B2 (en) | 2001-06-05 | 2009-05-26 | Alexza Pharmaceuticals, Inc. | Method of forming an aerosol for inhalation delivery |
| US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
| US7581540B2 (en) | 2004-08-12 | 2009-09-01 | Alexza Pharmaceuticals, Inc. | Aerosol drug delivery device incorporating percussively activated heat packages |
| US7585493B2 (en) | 2001-05-24 | 2009-09-08 | Alexza Pharmaceuticals, Inc. | Thin-film drug delivery article and method of use |
| US7645442B2 (en) | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
| US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
| US7981401B2 (en) | 2002-11-26 | 2011-07-19 | Alexza Pharmaceuticals, Inc. | Diuretic aerosols and methods of making and using them |
| US8235037B2 (en) | 2001-05-24 | 2012-08-07 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| US8387612B2 (en) | 2003-05-21 | 2013-03-05 | Alexza Pharmaceuticals, Inc. | Self-contained heating unit and drug-supply unit employing same |
| US11642473B2 (en) | 2007-03-09 | 2023-05-09 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
| US12214118B2 (en) | 2018-02-02 | 2025-02-04 | Alexza Pharmaceuticals, Inc. | Electrical condensation aerosol device |
-
1961
- 1961-05-09 GB GB1687461A patent/GB903866A/en not_active Expired
Cited By (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7232830B2 (en) | 1998-06-26 | 2007-06-19 | Elaine A Delack | Method for treatment of neurodegenerative diseases and effects of aging |
| WO2000000184A3 (en) * | 1998-06-26 | 2000-11-09 | Elaine A Delack | Use of histamine h2 mimicking substances for the treatment of multiple sclerosis |
| US9440034B2 (en) | 2001-05-24 | 2016-09-13 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| US7585493B2 (en) | 2001-05-24 | 2009-09-08 | Alexza Pharmaceuticals, Inc. | Thin-film drug delivery article and method of use |
| US9211382B2 (en) | 2001-05-24 | 2015-12-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| US8235037B2 (en) | 2001-05-24 | 2012-08-07 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| US7645442B2 (en) | 2001-05-24 | 2010-01-12 | Alexza Pharmaceuticals, Inc. | Rapid-heating drug delivery article and method of use |
| US7090830B2 (en) | 2001-05-24 | 2006-08-15 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| US10350157B2 (en) | 2001-05-24 | 2019-07-16 | Alexza Pharmaceuticals, Inc. | Drug condensation aerosols and kits |
| US7537009B2 (en) | 2001-06-05 | 2009-05-26 | Alexza Pharmaceuticals, Inc. | Method of forming an aerosol for inhalation delivery |
| US9687487B2 (en) | 2001-06-05 | 2017-06-27 | Alexza Pharmaceuticals, Inc. | Aerosol forming device for use in inhalation therapy |
| US7766013B2 (en) | 2001-06-05 | 2010-08-03 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
| US9439907B2 (en) | 2001-06-05 | 2016-09-13 | Alexza Pharmaceutical, Inc. | Method of forming an aerosol for inhalation delivery |
| US7942147B2 (en) | 2001-06-05 | 2011-05-17 | Alexza Pharmaceuticals, Inc. | Aerosol forming device for use in inhalation therapy |
| US8955512B2 (en) | 2001-06-05 | 2015-02-17 | Alexza Pharmaceuticals, Inc. | Method of forming an aerosol for inhalation delivery |
| US8074644B2 (en) | 2001-06-05 | 2011-12-13 | Alexza Pharmaceuticals, Inc. | Method of forming an aerosol for inhalation delivery |
| US11065400B2 (en) | 2001-06-05 | 2021-07-20 | Alexza Pharmaceuticals, Inc. | Aerosol forming device for use in inhalation therapy |
| US9308208B2 (en) | 2001-06-05 | 2016-04-12 | Alexza Pharmaceuticals, Inc. | Aerosol generating method and device |
| US7488469B2 (en) | 2001-11-21 | 2009-02-10 | Alexza Pharmaceuticals, Inc. | Delivery of caffeine through an inhalation route |
| WO2003057188A1 (en) * | 2001-11-21 | 2003-07-17 | Alexza Molecular Delivery Corporation | Delivery of caffeine through an inhalation route |
| US7078016B2 (en) | 2001-11-21 | 2006-07-18 | Alexza Pharmaceuticals, Inc. | Delivery of caffeine through an inhalation route |
| US7987846B2 (en) | 2002-05-13 | 2011-08-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
| US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
| US7981401B2 (en) | 2002-11-26 | 2011-07-19 | Alexza Pharmaceuticals, Inc. | Diuretic aerosols and methods of making and using them |
| US7913688B2 (en) | 2002-11-27 | 2011-03-29 | Alexza Pharmaceuticals, Inc. | Inhalation device for producing a drug aerosol |
| US8387612B2 (en) | 2003-05-21 | 2013-03-05 | Alexza Pharmaceuticals, Inc. | Self-contained heating unit and drug-supply unit employing same |
| US9370629B2 (en) | 2003-05-21 | 2016-06-21 | Alexza Pharmaceuticals, Inc. | Self-contained heating unit and drug-supply unit employing same |
| US8991387B2 (en) | 2003-05-21 | 2015-03-31 | Alexza Pharmaceuticals, Inc. | Self-contained heating unit and drug-supply unit employing same |
| US8333197B2 (en) | 2004-06-03 | 2012-12-18 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
| US7540286B2 (en) | 2004-06-03 | 2009-06-02 | Alexza Pharmaceuticals, Inc. | Multiple dose condensation aerosol devices and methods of forming condensation aerosols |
| US7581540B2 (en) | 2004-08-12 | 2009-09-01 | Alexza Pharmaceuticals, Inc. | Aerosol drug delivery device incorporating percussively activated heat packages |
| US11642473B2 (en) | 2007-03-09 | 2023-05-09 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
| US12138383B2 (en) | 2007-03-09 | 2024-11-12 | Alexza Pharmaceuticals, Inc. | Heating unit for use in a drug delivery device |
| US12214118B2 (en) | 2018-02-02 | 2025-02-04 | Alexza Pharmaceuticals, Inc. | Electrical condensation aerosol device |
| US12214119B2 (en) | 2018-02-02 | 2025-02-04 | Alexza Pharmaceuticals, Inc. | Electrical condensation aerosol device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB903866A (en) | Therapeutic preparations containing 7-substituted theophylline derivatives | |
| ZA711189B (en) | 1-(1,3,4-thiadiazol-2-yl)-imidazolidinone-(2)derivatives,process for their preparation and their use as herbicidal agents | |
| NL142941B (en) | PROCEDURE FOR PREPARING ACID DERIVATIVES AND ARTICLE OBTAINED UNDER APPLICATION OF THE PROCESS. | |
| GB930452A (en) | Improvements relating to the stabilisation of dihydroxyphenylalkyl amines | |
| ES2053765T3 (en) | ANTIBACTERIAL DERIVATIVES OF 9-DESOXO-9A-ALYL AND PROPARGIL-9A-AZA-9A-HOMOERYTHROMYCIN A. | |
| ES282914A1 (en) | Procedure for the obtaining of a dentºfrico (Machine-translation by Google Translate, not legally binding) | |
| NL7702175A (en) | PROCESS FOR THE PREPARATION OF SUBSTITUTED PURIN COMPONENTS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, AND PREPARATIONS CONTAINING THESE COMPONENTS AS AN ACTIVE COMPONENT. | |
| ES334729A1 (en) | A PROCEDURE FOR THE PREPARATION OF STABLE THEOPHYLLINE SOLUTIONS. | |
| GB918066A (en) | 1,2-diphenyl-4-carbamoyl-3,5-pyrazolidinedione and salts | |
| GB863538A (en) | An agent for softening callous skin | |
| GB1173322A (en) | Pharmaceutical Compositions containing Proscillaridin A | |
| NL153194B (en) | PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS CONTAINING AN ACID ADDITIONAL SALT OF A SUBSTITUTED PYRIDYL GROUP CONTAINING N-SUBSTITUATED DERIVATIVE OF THE N '- (3-P-FLUORBENZOYLPROEPORMINE, USED BEFORE INSERTING MEDIPROPROPYL, USED BEFORE INSERTING MEDIPROPROPYL) PREPARATION OF SUCH COMPOUNDS. | |
| GB938309A (en) | Bis-(ªâ-carbhydrazido-ethyl)-sulphone and process for preparing it | |
| GB954270A (en) | Lysine 4-hydroxybutyrate and process of preparation | |
| AU3211163A (en) | Process for preparation of hydrochloric acid solution of 3 - nitroso - 2-oxazolidone and aqueous acid solution of 3 - amino - 2 - oxazolidone hydrochloride therefrom | |
| GB884576A (en) | Pharmaceutical compositions comprising an alkylamino substituted barbituric acid and salts thereof | |
| ZA711188B (en) | 1-(1,3,4-thiadiazol-2-yl)-imidazolidinone-(2)derivatives,process for their preparation and their use as herbicidal agents | |
| CH422808A (en) | Process for the preparation of benzo (g) pteridine derivatives, in particular riboflavin | |
| GB877024A (en) | Improvements in or relating to steroid derivatives | |
| GB909878A (en) | Improvements in or relating to the manufacture of derivatives of nitrofuran | |
| CA593136A (en) | Sparingly water-soluble thiamine salts and process for preparing them | |
| GB840239A (en) | New anthelmintic compositions | |
| ES249787A1 (en) | Improvements in or relating to phenothiazine derivatives | |
| AU265043B2 (en) | New derivatives of pyrazine, process of preparing thesame and pharmaceutical preparations containing them | |
| AU654961A (en) | New derivatives of pyrazine, process of preparing thesame and pharmaceutical preparations containing them |